China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

Pozycja w akcjach #2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Cena akcji
$3.74
Kapitalizacja rynkowa
$6.23B
Zmiana (1 dzień)
-2.11%
Zmiana (1 rok)
-8.54%
Kraj
CN
Handel China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)

Kategoria

Healthcare
Przychody dla China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Przychody w Jun 2026 TTM: $4.76B
Według najnowszych raportów finansowych China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., obecny przychód firmy (TTM) wynosi $4.76B. W roku 2024 firma osiągnęła przychód w wysokości $3.78B wzrost w porównaniu do przychodu z roku 2023, który wynosił $3.49B. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. od 2001 do 2026
Przychody na koniec każdego roku
Rok Przychody Zmień
2026 (TTM) $4.76B 5.44%
2025 $4.52B 19.38%
2024 $3.78B 8.26%
2023 $3.49B 42.90%
2022 $2.45B 17.16%
2020 $2.09B -1.74%
2019 $2.12B 8.83%
2018 $1.95B 14.22%
2017 $1.71B 32.12%
2016 $1.29B 6.34%
2015 $1.22B 3.56%
2014 $1.17B -2.29%
2013 $1.20B 7.98%
2012 $1.11B 28.69%
2011 $865.22M 30.83%
2010 $661.34M -6.96%
2009 $710.79M 12.37%
2008 $632.54M 35.93%
2007 $465.35M 26.67%
2006 $367.39M -0.13%
2005 $367.88M 23.67%
2004 $297.46M -7.95%
2003 $323.17M 23.51%
2002 $261.66M 15.95%
2001 $225.66M 0.00%
Przychody podobnych firm lub konkurentów
Firma Przychody Różnica w przychodach Kraj
$23.54B 394.15%
DE
$23.73B 398.34%
DE
$29.24B 513.92%
JP
$5.85B 22.80%
CH
$6.34B 33.16%
IN